Process for preparing an aqueous solution of a methylcellulose

US10624376B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10624376-B2
Application numberUS-201715793208-A
CountryUS
Kind codeB2
Filing dateOct 25, 2017
Priority dateApr 12, 2013
Publication dateApr 21, 2020
Grant dateApr 21, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A process for preparing an aqueous solution of a methylcellulose having anhydroglucose units joined by 1-4 linkages wherein hydroxy groups of anhydroglucose units are substituted with methyl groups such that s23/s26 is 0.36 or less, wherein s23 is the molar fraction of anhydroglucose units wherein only the two hydroxy groups in the 2- and 3-positions of the anhydroglucose unit are substituted with methyl groups and wherein s26 is the molar fraction of anhydroglucose units wherein only the two hydroxy groups in the 2- and 6-positions of the anhydroglucose unit are substituted with methyl groups, comprises the step of mixing the methylcellulose with an aqueous liquid at a temperature of not higher than 10° C. at a shear rate of at least 1000 s −1 .

First claim

Opening claim text (preview).

The invention claimed is: 1. A protein-free aqueous solution of a methyl cellulose (MC), wherein the MC concentration is from 0.2 to 2.5 percent and the aqueous solution has a gel fracture force F GF (37° C.) of i) at least 1.4 N when the MC concentration is from 0.2 to 0.4 percent, ii) at least 2.0 N when the MC concentration is from 0.5 to 0.7 percent, iii) at least 2.5 N when the MC concentration is from 0.8 to 1.0 percent, iv) at least 3.5 N when the MC concentration is from 1.1 to 1.3 percent, v) at least 4.5 N when the MC concentration is from 1.4 to 1.6 percent, vi) at least 9.0 N when the MC concentration is from 1.7 to 1.9 percent, vii) at least 11.0 N when the MC concentration is from 2.0 to 2.2 percent, or viii) at least 13.0 N when the MC concentration is from 2.3 to 2.5 percent, based on the total weight of the aqueous solution, and having a gel fracture force F GF (37° C.) of 1.4 N to 20 N when the MC concentration is 0.2 to 1.6 percent and a gel fracture force F GF (37° C.) of 1.4 N to 75 N when the MC concentration is from 0.2 to 2.5 percent and the methylcellulose has anhydroglucose units joined by 1-4 linkages wherein hydroxy groups of anhydroglucose units are substituted with methyl groups such that s23/s26 is 0.27 or less, wherein s23 is the molar fraction of anhydroglucose units wherein only the two hydroxy groups in the 2- and 3-positions of the anhydroglucose unit are substituted with methyl groups and s26 is the molar fraction of anhydroglucose units wherein only the two hydroxy groups in the 2-and 6-positions of the anhydroglucose unit are substituted with methyl groups. 2. The protein-free aqueous solution of claim 1 wherein the concentration of the methylcellulose (MC) is from 0.8 to 2.2 percent and the aqueous solution has a gel fracture force F GF (37° C.) of at least 2.5 N when the MC concentration is from 0.8 to 1.0 percent, at least 3.5 N when the MC concentration is from 1.1 to 1.3 percent, at least 4.5 N when the MC concentration is from 1.4 to 1.6 percent, at least 9.0 N when the MC concentration is from 1.7 to 1.9 percent, or at least 11.0 N when the MC concentration is from 2.0 to 2.2 percent, based on the total weight of the aqueous solution. 3. The protein-free aqueous solution of claim 1 wherein the concentration of the methylcellulose (MC) is from 0.2 to 2.2 percent and the aqueous solution has a gel fracture force F GF (37° C.) of i) at least 1.8 N when the MC concentration is 0.2 to 0.4 percent, ii) at least 2.5 N when the MC concentration is from 0.5 to 0.7 percent, iii) at least 3.0 N when the MC concentration is from 0.8 to 1.0 percent, iv) at least 4.5 N when the MC concentration is from 1.1 to 1.3 percent, v) at least 5.0 N when the MC concentration is from 1.4 to 1.6 percent, vi) at least 10.0 N when the MC concentration is from 1.7 to 1.9 percent, or vii) at least 12.0 N when the MC concentration is from 2.0 to 2.2 percent, based on the total weight of the aqueous solution. 4. The protein-free aqueous solution of claim 1 wherein the aqueous solution has been prepared by dissolving the methylcellulose in water at a temperature of not higher than 5° C. at a shear rate of at least 1000 s −1 . 5. The protein-free aqueous solution of claim 1 wherein the viscosity of the methylcellulose is from 200 to 10000 mPa·s, when measured as a 2 wt. % solution in water at 5° C. at a shear rate of 10 s −1 . 6. The protein-free aqueous solution of claim 1 wherein the methylcellulose has a DS(methyl) of from 1.55 to 2.25. 7. A medicament, food, food ingredient or food supplement comprising or being made of the protein-free aqueous solution of claim 1 . 8. A method of reducing caloric intake, inducing satiety or reversibly reducing stomach void volume in an individual or of treating gastric ulcers, gastro-esophageal reflux disease, or obesity, or of aiding slimming, weight loss, or weight control in a non-obese individual, comprising the step of administering to said individual the protein-free aqueous solution of claim 1 . 9. The method of claim 8 , wherein the individual is not obese. 10. A method of reducing caloric intake, inducing satiety or reversibly reducing stomach void volume in an individual or of treating gastric ulcers, gastro-esophageal reflux disease, or obesity, or of aiding slimming, weight loss, or weight control in a non-obese individual, comprising the step of administering to said individual the medicament, food, food ingredient or food supplement of claim 7 . 11. The method of claim 10 , wherein the individual is not obese.

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10624376B2 cover?
A process for preparing an aqueous solution of a methylcellulose having anhydroglucose units joined by 1-4 linkages wherein hydroxy groups of anhydroglucose units are substituted with methyl groups such that s23/s26 is 0.36 or less, wherein s23 is the molar fraction of anhydroglucose units wherein only the two hydroxy groups in the 2- and 3-positions of the anhydroglucose unit are substitu…
Who is the assignee on this patent?
Dow Global Technologies Llc
What technology area does this patent fall under?
Primary CPC classification A23L29/262. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Apr 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 3 related publications on this page (citations in our corpus or others sharing the same primary CPC).